Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$17.21 - $25.28 $1.22 Million - $1.8 Million
-71,092 Reduced 63.99%
40,000 $935,000
Q2 2024

Aug 14, 2024

BUY
$13.32 - $19.19 $1.48 Million - $2.13 Million
111,092 New
111,092 $1.98 Million
Q4 2023

Feb 14, 2024

BUY
$6.68 - $18.81 $512,549 - $1.44 Million
76,729 New
76,729 $1.31 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.79B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Lighthouse Investment Partners, LLC Portfolio

Follow Lighthouse Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lighthouse Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lighthouse Investment Partners, LLC with notifications on news.